Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis
Michael Andersen, Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell · 2024
Read Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis by Michael Andersen, Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11696637.txt.
Description
Michael Andersen and co-authors study adults with cancer who had a clot in the veins of the belly, and ask what a low platelet count at the start means for their care. Platelets help blood clot, so a low count could raise fears of bleeding if clot drugs are used.
The single center study covered 581 patients. Close to four in ten had a low platelet count near the time the clot was found. Over a year, major bleeding and clot growth or return were both seen in a fair share. In the main tests, a low count at the start did not on its own track with either outcome.
Catalog record
| CREATOR | Michael Andersen, Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |